A Texas genetic engineering company claims it has developed a possible vaccine against the coronavirus.
An executive with Houston-based Greffex says their researchers use a genetic adenovirus-based platform that enables them to create any vaccine quickly. Greffex produced a vaccine for Middle East Respiratory Syndrome in 2015, and since MERS is similar to the coronavirus, they based the new vaccine on that research.
The company needs government funding for animal testing, and then will need FDA approval to conduct human trials. It’s possible the vaccine could be ready by year’s end or the FDA could fast track it.
Another possible vaccine is already in the first stages of testing and was developed by National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci and his team.